CoNotes

Aridis is a privately held biopharmaceutical company formed in 2003, which uses pioneering formulation, processing, and delivery technologies to produce differentiated, high value products. Aridisí goal is to develop antibodies and vaccines that are more convenient and cost effective for both the recipient and the health professional by simplifying their storage and administration. Our initial products target infectious diseases that have a significant impact on life expectancy, such as infectious diseases in children and cystic fibrosis (CF) in adults and children. Aridis has three licensed products: two with preclinical data, and one with phase II clinical efficacy data.

(Source: Aridis)